Cutaneous vascular conductance at baseline and maximum (28mM SNP + 43°C local heat) in control (Ringers) and NOS-inhibited (L-NAME) microdialysis sites following placebo and salsalate treatments in women with a history of healthy pregnancy (HC) and women with a history of preeclampsia (PE). No differences (all p>0.05).

Table 3. Cutaneous Vascular Conductance (flux·mmHg−1)	HC (n=12)	PE (n=10)
Baseline
Ringers
placebo	0.2±0.1	0.2±0.0
salsalate	0.1±0.0	0.1±0.0
L-NAME
placebo	0.1±0.0	0.2±0.0
salsalate	0.1±0.0	0.1±0.0
Maximal
Ringers
placebo	1.8±0.2	1.8±0.2
salsalate	1.5±0.2	1.8±0.3
L-NAME
placebo	1.9±0.2	1.7±0.2
salsalate	1.6±0.1	1.9±0.3